Tag: PAMA
In the CY 2021 MPFS Proposed Rule, CMS solicited comments on whether the two specimen collection codes (G2023 and G2024), established during the COVID-19 PHE, should be deleted or should remain after the PHE has ended. These codes were created for in...
On March 27, 2020, the President signed the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The CARES Act represents the third largest stimulus bill passed by Congress in response to the COVID-19 pandemic and with $2 trillion in allocatio...
Following the passage of the LAB Act, CMS issued a transmittal that specifies the new data reporting period for Clinical Diagnostic Laboratory Tests (CDLTs) that are not Advanced Diagnostic Laboratory Tests (ADLTs) (delayed until January 1 – March ...
On December 19, Congress passed the Laboratory Access for Beneficiaries (LAB) Act as part of an end-of-year spending package signed into law by the President on December 20. The LAB Act has been a priority for a number of stakeholders in the laborato...
CMS has published its application for new “U” codes for advanced diagnostic laboratory tests (ADLTs) and FDA-cleared or approved clinical diagnostic laboratory tests (CDLTs). These new “U” codes are intended to describe a single test. Reviews...
The Centers for Medicare and Medicaid Services has released the final CY 2019 payment rates for clinical diagnostic services along with supporting instructional materials. These rates are effective for claims with dates of service on or after Janua...
On September 20, the Office of the Inspector General (OIG) released the fourth in a series of data briefs looking at Medicare spending under the Clinical Laboratory Fee Schedule. This report evaluates Medicare spending in 2017, the final year befor...
On Monday December 11, the American Clinical Laboratory Association (ACLA) filed a legal challenge to CMS’s implementation of the revised Clinical Laboratory Fee Schedule (CLFS) required under Section 216 of the Protecting Access to Medicare Act ...
The Centers for Medicare and Medicaid Services today posted the long-awaited proposed rule to implement section 216 of the Protecting Access to Medicare Act, which when finalized, will revamp how CMS determines payment amounts for laboratory se...
